US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apollomics

0.0149

0.0000

Volume:- -

Turnover:- -

Market Cap:16.44K

PE:- -

High:0.0149

Open:0.0149

Low:0.0149

Close:0.0149

52wk High:0.0489

52wk Low:0.0047

Shares:1.10M

Float Shares:1.10M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Apollomics H1 EPS $(11.37) Up From $(37.53) YoY, Sales $8.500K

Press Release: Apollomics Reports First Half 2025 Financial Results

Apollomics Announces Settlement of Cayman Litigation

Apollomics Announces Changes to Its Board of Directors and Composition of Committees

THOMSON REUTERS

Press Release: Apollomics Announces Changes to its Board of Directors and Composition of Committees

Apollomics says securities to remain listed on Nasdaq

Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation

Apollomics, Inc. Company Operational Continuity Update

Nasdaq halts Apollomics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/APLMW/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APLMW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APLMW\",,,,,undefined,":{"symbol":"APLMW","market":"US","secType":"STK","nameCN":"Apollomics","latestPrice":0.0149,"timestamp":1771016400000,"preClose":0.0149,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":1103333,"shares":1103333,"eps":0,"marketStatus":"Closed President's Day","change":0,"latestTime":"02-13 16:00:00 EST","open":0.0149,"high":0.0149,"low":0.0149,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0149,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APLMW\",,,,,undefined,":{"symbol":"APLMW","floatShares":1103333,"roa":"--","roe":"--","lyrEps":0,"shares":1103333,"dividePrice":0,"high":0.0149,"amplitude":0,"preClose":0.0149,"low":0.0149,"week52Low":0.0047,"pbRate":"--","week52High":0.0489,"institutionHeld":0,"latestPrice":0.0149,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.0149,"prevYearClose":0.0111,"prevWeekClose":0.0149,"prevMonthClose":0.0147,"prevQuarterClose":0.0111,"fiveDayClose":0.0142,"twentyDayClose":0.0145,"sixtyDayClose":0.019},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APLMW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APLMW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APLMW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APLMW\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2593572458","title":"Apollomics H1 EPS $(11.37) Up From $(37.53) YoY, Sales $8.500K","url":"https://stock-news.laohu8.com/highlight/detail?id=2593572458","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593572458?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:07","pubTimestamp":1766437662,"startTime":"0","endTime":"0","summary":"Apollomics H1 EPS $(11.37) Up From $(37.53) YoY, Sales $8.500K","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/12/49549437/apollomics-h1-eps-11-37-up-from-37-53-yoy-sales-8-500k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Apollomics H1 EPS $(11.37) Up From $(37.53) YoY, Sales $8.500K","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLMW"],"gpt_icon":0},{"id":"2593508458","title":"Press Release: Apollomics Reports First Half 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2593508458","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593508458?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:05","pubTimestamp":1766437500,"startTime":"0","endTime":"0","summary":"FOSTER CITY, Calif., Dec. 22, 2025  -- Apollomics Inc.  , a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced financial results for the first half of 2025 ended June 30, 2025.First Half 2025 Financial Results Ended June 20, 2025. -- Cash, cash equivalents, bank deposits and money market funds as of June. 30, 2025, were $2.1 million, compared to $9.8 million as of December 31,2024. Based on current projections, the Company believes its cash. -- Research and development (R&D) expenses were $4.6 million, including. share-based compensation of $0.8 million, for the first half of 2025,compared to $16.9 million, including share-based compensation of $3.7. share-based compensation of $2.5 million, for the first half of 2025,-- Net loss for the first half of 2025 was $ million, or $ per. basic and diluted share, compared to a net loss of $ million, or","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLM","APLMW","BK4139"],"gpt_icon":0},{"id":"2584997150","title":"Apollomics Announces Settlement of Cayman Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2584997150","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584997150?lang=en_us&edition=fundamental","pubTime":"2025-11-20 06:38","pubTimestamp":1763591880,"startTime":"0","endTime":"0","summary":"FOSTER CITY, Calif., Nov.  19, 2025  (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”) (Nasdaq: APLM) announced today entering into a settlement agreement (the “Settlement Agreement”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/19/3191516/0/en/Apollomics-Announces-Settlement-of-Cayman-Litigation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLMW"],"gpt_icon":0},{"id":"2584607005","title":"Apollomics Announces Changes to Its Board of Directors and Composition of Committees","url":"https://stock-news.laohu8.com/highlight/detail?id=2584607005","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584607005?lang=en_us&edition=fundamental","pubTime":"2025-11-18 12:00","pubTimestamp":1763438400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUA1WR9ST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APLM","APLMW"],"gpt_icon":0},{"id":"2584600871","title":"Press Release: Apollomics Announces Changes to its Board of Directors and Composition of Committees","url":"https://stock-news.laohu8.com/highlight/detail?id=2584600871","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584600871?lang=en_us&edition=fundamental","pubTime":"2025-11-18 12:00","pubTimestamp":1763438400,"startTime":"0","endTime":"0","summary":"FOSTER CITY, Calif., Nov. 17, 2025  -- Apollomics Inc.  , a California-based late-stage clinical biopharmaceutical company, today announced the following update regarding changes to the Company's board of directors  and composition of committees.On November 16, 2025, Mr. Po-Jen Hsueh resigned from the Board. Mr. Hsueh's resignation was not related to any disagreement with the Company.Pursuant to a meeting of the Board on November 16, 2025, Dr. Ya-Chi  Huang was appointed to the Board to fill the vacancy resulting from Mr. Hsueh's resignation. Dr. Ya-Chi  Huang will also replace Mr. Po-Jen Hsueh as a member of the Company's Audit Committee and Nominating and Corporate Governance Committee. Following these changes and the previously announced appointments of directors, the Company's Board is comprised of the following seven members: Hung-Wen  Chen , Hong-Jung  Chen, Yi-Kuei Chen, Hsien-Shu Tsai, Yi-An Chu, Chen-Huan Jan, and Ya-Chi  Huang. Moses Chen, Hsien-Shu Tsai, Yi-An Chu, Chen-Huan","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLM","BK4139","APLMW"],"gpt_icon":0},{"id":"2575755316","title":"Apollomics says securities to remain listed on Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2575755316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575755316?lang=en_us&edition=fundamental","pubTime":"2025-10-16 02:45","pubTimestamp":1760553914,"startTime":"0","endTime":"0","summary":"Apollomics (APLM) notes it had previously announced that it had filed an application to appeal the delisting notification previously received from ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apollomics-says-securities-to-remain-listed-on-nasdaq-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apollomics-says-securities-to-remain-listed-on-nasdaq-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSQ","USAW.SI","QLD",".IXIC","NQmain","APLMW","BK4139","USJW.SI","APLM","NVIW.SI","QID","TQQQ","MNQmain","SQQQ","TSYW.SI"],"gpt_icon":0},{"id":"2575587507","title":"Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2575587507","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575587507?lang=en_us&edition=fundamental","pubTime":"2025-10-16 02:36","pubTimestamp":1760553360,"startTime":"0","endTime":"0","summary":"Nasdaq Hearing Cancellation and Continued ListingFOSTER CITY, Calif., Oct.  15, 2025  (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California based late-stage ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/15/3167416/0/en/Apollomics-Announces-Continued-Listing-on-The-Nasdaq-Stock-Market-Following-Hearing-Cancellation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLMW","QID","TQQQ",".IXIC","USAW.SI","QLD","NQmain","MNQmain","TSYW.SI","NVIW.SI","USJW.SI","SQQQ","PSQ"],"gpt_icon":1},{"id":"2575307032","title":"Apollomics, Inc. Company Operational Continuity Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2575307032","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575307032?lang=en_us&edition=fundamental","pubTime":"2025-10-14 09:22","pubTimestamp":1760404920,"startTime":"0","endTime":"0","summary":"FOSTER CITY, Calif., Oct.  13, 2025  (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), today announced the following company operational update. Apollomics is a clini","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/14/3165856/0/en/Apollomics-Inc-Company-Operational-Continuity-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLMW"],"gpt_icon":0},{"id":"2568105514","title":"Nasdaq halts Apollomics","url":"https://stock-news.laohu8.com/highlight/detail?id=2568105514","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568105514?lang=en_us&edition=fundamental","pubTime":"2025-09-18 05:56","pubTimestamp":1758146160,"startTime":"0","endTime":"0","summary":"Nasdaq (NDAQ) announced that trading was halted on September 17 in Apollomics (APLM) at 14:37:17 Eastern Time for additional information requested ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nasdaq-halts-apollomics-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nasdaq-halts-apollomics-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","USAW.SI","TQQQ","SQQQ",".IXIC","BK4112","APLMW","QID","TSYW.SI","USJW.SI","MNQmain","LU0314104364.USD","NVIW.SI","NDAQ","NQmain","IE00BKPKM429.USD","IE00B64PRP62.GBP","QLD","LU2095319765.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","PSQ","APLM","LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}